Answer
Not in the selected product licences. Specialist paediatric services may nevertheless use it for symptomatic congenital CMV as a non-licensed treatment.
Sources for this answer
- Valcyte 50 mg/ml powder for oral solution — Current selected SmPCemc · Summary of Product Characteristics
- Valcyte 450mg film-coated tablets — Current selected SmPCemc · Summary of Product Characteristics